Cancer News and Research

Latest Cancer News and Research

Two recent experimental treatments improve visual function in mouse models of retinitis pigmentosa

Two recent experimental treatments - one involving skin-derived induced pluripotent stem (iPS) cell grafts, the other gene therapy - have been shown to produce long-term improvement in visual function in mouse models of retinitis pigmentosa (RP), according to the Columbia University Medical Center (CUMC) scientists who led the studies. At present, there is no cure for RP, the most common form of inherited blindness.

20 Dec 2012

Maternal vitamin D deficiency could cause low birth weight

Women deficient in vitamin D early in their pregnancies are more likely to deliver babies with lower birth weights, University of Pittsburgh Graduate School of Public Health research reveals.

20 Dec 2012

Biotest receives FDA approval for BIVIGAM to treat primary humoral immunodeficiency

Biotest AG announced today that Biotest Pharmaceuticals Corporation received approval for BIVIGAM for the treatment of patients with Primary Humoral Immunodeficiency (PI) from the U.S. Food and Drug Administration (FDA).

20 Dec 2012

Proteins detected in urine may enable diagnosis of Kawasaki disease

A set of proteins detected in urine by researchers at Boston Children's Hospital may prove to be the first biomarkers for Kawasaki disease, an uncommon but increasingly prevalent disease which causes inflammation of blood vessels that can lead to enlarged coronary arteries and even heart attacks in some children.

20 Dec 2012

Cancer-related mortality increased in psychiatric patients

The incidence of cancer is lower in psychiatric patients than the general population, but associated mortality rates are higher, researchers report.

20 Dec 2012

Slushy spares kidney during partial nephrectomy

US researchers report the success and feasibility of a novel method of carrying out partial nephrectomy in kidney patients, using minimally invasive surgery.

20 Dec 2012

Coffee habit improves survival chances with oral cancer

Drinking more than four cups of coffee per day lowers the risk for death from oral/pharyngeal cancer by almost half compared with drinking none, according to US study findings.

20 Dec 2012

Palliative care consultation may benefit heart failure patients

Symptomatic heart failure patients experience a high prevalence of pain and symptom burden akin to the experiences of cancer patients, say researchers, who report that a palliative care consultation in this population could reduce these factors.

20 Dec 2012

FUS RNA binding ability essential for development of Amyotrophic Lateral Sclerosis

Research led by Dr. Udai Pandey, Assistant Professor of Genetics at LSU Health Sciences Center New Orleans, has found that the ability of a protein made by a gene called FUS to bind to RNA is essential to the development of Amyotrophic Lateral Sclerosis (ALS). This discovery identifies a possible therapeutic target for the fatal neurological disease.

20 Dec 2012

Rwanda implementing programs to prevent cancer

In a Huffington Post "Impact" blog post, Tom Murphy, founder of the development blog "A View From The Cave," examines Rwanda's efforts to reduce cancer incidence by implementing screening programs for breast and cervical cancers and vaccinating girls and young women for human papillomavirus (HPV), the leading cause of cervical cancer.

20 Dec 2012

V-chip could allow health care providers to do 50 different tests in one go

A new device about the size of a business card could allow health care providers to test for insulin and other blood proteins, cholesterol, and even signs of viral or bacterial infection all at the same time—with one drop of blood. Preliminary tests of the V-chip, created by scientists at The Methodist Hospital Research Institute and MD Anderson Cancer Center, were published last night by Nature Communications.

20 Dec 2012

Newtown shooting spotlights gaps in mental health care

The elementary school massacre prompts an examination of mental health care policies and access to guns by the mentally ill.

20 Dec 2012

Study focuses on hormone-sensitive breast tumours

Gene expression in breast cancer provides valuable biological information for better determining the diagnosis, treatment, risk of relapse and survival rate. However, the most common form of characterizing breast cancer is by histopathological techniques. This study, headed by Dr Aleix Prat, Head of the Translational Genomics Group at the Vall d'Hebron Institute of Oncology (VHIO) and an oncologist at the Breast Cancer Unit of the Vall d´Hebron University Hospital, focused on hormone-sensitive breast tumours known as luminals.

20 Dec 2012

Study finds no clear indication 9/11 debris causes cancer

The study, published in the Journal of the American Medical Association, examined the health of nearly 56,000 people.

20 Dec 2012

Scientists uncover TDP-43 protein as possible target for treatment of ALS, FTD

Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases - amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) - and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.

20 Dec 2012

Patients with hypertension or diabetes have increased risk of cancer recurrence, survival

By all accounts, a combination of colon cancer, diabetes and high blood pressure can be a recipe for medical disaster. Now, a new study led by a surgical oncologist and researcher at Temple University School of Medicine and Fox Chase Cancer Center has shown just how deadly this mix can be.

20 Dec 2012

GI bacteria exert some control over their hosts' appetites: Review

Over the last half decade, it has become increasingly clear that the normal gastrointestinal (GI) bacteria play a variety of very important roles in the biology of human and animals. Now Vic Norris of the University of Rouen, France, and coauthors propose yet another role for GI bacteria: that they exert some control over their hosts' appetites.

20 Dec 2012

Investigators report non-coding miRNAs as appealing biomarkers for cancer malignancy

As many as 50 percent of all human protein-coding genes are regulated by microRNA (miRNA) molecules. While some miRNAs impact onset and progression of cancer, others can actually suppress the development of malignant tumors and are useful in cancer therapy. They can also serve as potential biomarkers for early cancer detection. In a new issue of Cancer Biomarkers, investigators report on non-coding miRNAs as appealing biomarkers for malignancy.

20 Dec 2012

Positive top-line results from Idera’s IMO-3100 Phase 2a trial on plaque psoriasis

Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.

20 Dec 2012

New therapeutic ultrasound approach could lead to an invisible knife for noninvasive surgery

A carbon-nanotube-coated lens that converts light to sound can focus high-pressure sound waves to finer points than ever before. The University of Michigan engineering researchers who developed the new therapeutic ultrasound approach say it could lead to an invisible knife for noninvasive surgery.

20 Dec 2012

Cancer News and Research

Latest Cancer News and Research

Two recent experimental treatments improve visual function in mouse models of retinitis pigmentosa

Maternal vitamin D deficiency could cause low birth weight

Biotest receives FDA approval for BIVIGAM to treat primary humoral immunodeficiency

Proteins detected in urine may enable diagnosis of Kawasaki disease

Cancer-related mortality increased in psychiatric patients

Slushy spares kidney during partial nephrectomy

Coffee habit improves survival chances with oral cancer

Palliative care consultation may benefit heart failure patients

FUS RNA binding ability essential for development of Amyotrophic Lateral Sclerosis

Rwanda implementing programs to prevent cancer

V-chip could allow health care providers to do 50 different tests in one go

Newtown shooting spotlights gaps in mental health care

Study focuses on hormone-sensitive breast tumours

Study finds no clear indication 9/11 debris causes cancer

Scientists uncover TDP-43 protein as possible target for treatment of ALS, FTD

Patients with hypertension or diabetes have increased risk of cancer recurrence, survival

GI bacteria exert some control over their hosts' appetites: Review

Investigators report non-coding miRNAs as appealing biomarkers for cancer malignancy

Positive top-line results from Idera’s IMO-3100 Phase 2a trial on plaque psoriasis

New therapeutic ultrasound approach could lead to an invisible knife for noninvasive surgery

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in